IBDEI0FN ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21125,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,21125,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,21125,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,21126,0)
 ;;=250.50^^133^1352^25
 ;;^UTILITY(U,$J,358.3,21126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21126,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,21126,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,21126,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,21127,0)
 ;;=250.51^^133^1352^27
 ;;^UTILITY(U,$J,358.3,21127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21127,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,21127,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,21127,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,21128,0)
 ;;=362.01^^133^1352^32
 ;;^UTILITY(U,$J,358.3,21128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21128,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,21128,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,21128,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,21129,0)
 ;;=362.02^^133^1352^72
 ;;^UTILITY(U,$J,358.3,21129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21129,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,21129,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,21129,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,21130,0)
 ;;=362.03^^133^1352^64
 ;;^UTILITY(U,$J,358.3,21130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21130,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,21130,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,21130,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,21131,0)
 ;;=362.04^^133^1352^61
 ;;^UTILITY(U,$J,358.3,21131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21131,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,21131,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,21131,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,21132,0)
 ;;=362.05^^133^1352^62
 ;;^UTILITY(U,$J,358.3,21132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21132,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,21132,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,21132,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,21133,0)
 ;;=362.06^^133^1352^98
 ;;^UTILITY(U,$J,358.3,21133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21133,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,21133,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,21133,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,21134,0)
 ;;=379.27^^133^1352^103
 ;;^UTILITY(U,$J,358.3,21134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21134,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,21134,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,21134,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,21135,0)
 ;;=115.02^^133^1352^44
 ;;^UTILITY(U,$J,358.3,21135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21135,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,21135,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,21135,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,21136,0)
 ;;=190.5^^133^1352^58
 ;;^UTILITY(U,$J,358.3,21136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21136,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,21136,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,21136,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,21137,0)
 ;;=198.4^^133^1352^59
 ;;^UTILITY(U,$J,358.3,21137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21137,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,21137,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,21137,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,21138,0)
 ;;=200.00^^133^1352^81
 ;;^UTILITY(U,$J,358.3,21138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21138,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,21138,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,21138,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,21139,0)
 ;;=228.03^^133^1352^38
 ;;^UTILITY(U,$J,358.3,21139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21139,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,21139,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,21139,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,21140,0)
 ;;=228.09^^133^1352^39
 ;;^UTILITY(U,$J,358.3,21140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21140,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,21140,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,21140,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,21141,0)
 ;;=360.00^^133^1352^73
 ;;^UTILITY(U,$J,358.3,21141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21141,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,21141,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,21141,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,21142,0)
 ;;=360.03^^133^1352^21
 ;;^UTILITY(U,$J,358.3,21142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21142,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,21142,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,21142,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,21143,0)
 ;;=361.02^^133^1352^76
 ;;^UTILITY(U,$J,358.3,21143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21143,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,21143,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,21143,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,21144,0)
 ;;=361.03^^133^1352^75
 ;;^UTILITY(U,$J,358.3,21144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21144,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,21144,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,21144,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,21145,0)
 ;;=361.04^^133^1352^79
 ;;^UTILITY(U,$J,358.3,21145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21145,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,21145,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,21145,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,21146,0)
 ;;=361.12^^133^1352^8
 ;;^UTILITY(U,$J,358.3,21146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21146,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,21146,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,21146,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,21147,0)
 ;;=361.2^^133^1352^102
 ;;^UTILITY(U,$J,358.3,21147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21147,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,21147,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,21147,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,21148,0)
 ;;=361.9^^133^1352^83
 ;;^UTILITY(U,$J,358.3,21148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21148,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,21148,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,21148,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,21149,0)
 ;;=362.10^^133^1352^95
 ;;^UTILITY(U,$J,358.3,21149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21149,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,21149,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,21149,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,21150,0)
 ;;=362.12^^133^1352^22
 ;;^UTILITY(U,$J,358.3,21150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21150,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,21150,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,21150,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,21151,0)
 ;;=362.13^^133^1352^88
 ;;^UTILITY(U,$J,358.3,21151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21151,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,21151,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,21151,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,21152,0)
 ;;=362.14^^133^1352^82
 ;;^UTILITY(U,$J,358.3,21152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21152,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,21152,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,21152,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,21153,0)
 ;;=362.17^^133^1352^52
 ;;^UTILITY(U,$J,358.3,21153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21153,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,21153,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,21153,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,21154,0)
 ;;=362.21^^133^1352^71
 ;;^UTILITY(U,$J,358.3,21154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21154,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,21154,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,21154,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,21155,0)
 ;;=362.29^^133^1352^63
 ;;^UTILITY(U,$J,358.3,21155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21155,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,21155,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,21155,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,21156,0)
 ;;=362.30^^133^1352^40
 ;;^UTILITY(U,$J,358.3,21156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21156,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,21156,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,21156,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,21157,0)
 ;;=362.37^^133^1352^9
 ;;^UTILITY(U,$J,358.3,21157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21157,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,21157,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,21157,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,21158,0)
 ;;=362.50^^133^1352^51
 ;;^UTILITY(U,$J,358.3,21158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21158,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,21158,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,21158,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,21159,0)
 ;;=362.70^^133^1352^28
 ;;^UTILITY(U,$J,358.3,21159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21159,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,21159,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,21159,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,21160,0)
 ;;=362.74^^133^1352^91
 ;;^UTILITY(U,$J,358.3,21160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21160,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,21160,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,21160,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,21161,0)
 ;;=362.75^^133^1352^50
 ;;^UTILITY(U,$J,358.3,21161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21161,1,3,0)
 ;;=3^Mac Degen,Juvenile
 ;;^UTILITY(U,$J,358.3,21161,1,4,0)
 ;;=4^362.75
 ;;^UTILITY(U,$J,358.3,21161,2)
 ;;=^268656
